Press Release Details

Quest Diagnostics CEO and CFO File Sworn Statements With The SEC Certifying The Accuracy of Company Financial Reports


TETERBORO, N.J., Aug 13, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, and Robert A. Hagemann, Chief Financial Officer, submitted unqualified sworn statements to the Securities and Exchange Commission certifying the accuracy of the company's recent SEC filings.

The certifications, which were also disclosed as exhibits to a Form 8-K filed this morning, were made to comply with Securities and Exchange Commission Order 4-460 and Section 906 of the Sarbanes-Oxley Act of 2002. The statements made under SEC Order 4-460 cover the company's Annual Report on Form 10-K for the year ended December 31, 2001, as well as the 2002 Proxy Statement and all subsequently filed reports on Forms 10-Q and 8-K.

To review Quest Diagnostics' recent 8-K or other SEC filings, investors and others may access the Quest Diagnostics website at:

Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers patients and physicians the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at:

The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are described in the Quest Diagnostics Incorporated 2001 Form 10-K and subsequent filings.

SOURCE Quest Diagnostics Incorporated

Laure Park - Investors, +1-201-393-5030, or Gary Samuels -
Media, +1-201-393-5700, both of Quest Diagnostics


Copyright (C) 2002 PR Newswire. All rights reserved.